SofWave Medical Ltd. (TLV: SOFW)
Israel
· Delayed Price · Currency is ILS · Price in ILA1,649.00
-1.00 (-0.06%)
Dec 22, 2024, 2:36 PM IDT
SofWave Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 56.64 | 50.32 | 35.63 | 21.84 | 4.29 | 0.28 |
| Revenue Growth (YoY) | 16.07% | 41.22% | 63.15% | 408.95% | 1443.53% | - |
| Cost of Revenue | 13.95 | 13.01 | 9.44 | 5.63 | 1.67 | 0.11 |
| Gross Profit | 42.69 | 37.3 | 26.19 | 16.21 | 2.62 | 0.17 |
| Selling, General & Admin | 35.7 | 34.04 | 31.23 | 17 | 4.59 | 0.71 |
| Research & Development | 10.64 | 11.25 | 12.3 | 8.21 | 4.58 | 2.61 |
| Operating Expenses | 46.34 | 45.29 | 43.53 | 25.21 | 9.17 | 3.33 |
| Operating Income | -3.65 | -7.99 | -17.34 | -9 | -6.55 | -3.16 |
| Interest Expense | -0.23 | -0.06 | -0.19 | -0.11 | -0.04 | -0 |
| Interest & Investment Income | 0.9 | 0.78 | 0.33 | 0.03 | 0.01 | 0.02 |
| Currency Exchange Gain (Loss) | 0.02 | 0.02 | -1.07 | 2.26 | -0.11 | -0.18 |
| Other Non Operating Income (Expenses) | -1 | -1 | -0.94 | -0.46 | -0.3 | -0.23 |
| EBT Excluding Unusual Items | -3.95 | -8.26 | -19.21 | -7.28 | -6.98 | -3.55 |
| Other Unusual Items | - | - | 0 | 0.14 | -4.7 | 0.1 |
| Pretax Income | -3.95 | -8.26 | -19.21 | -7.15 | -11.69 | -3.45 |
| Income Tax Expense | 0.26 | 0.02 | 0.32 | -0.32 | - | - |
| Net Income | -4.22 | -8.28 | -19.53 | -6.83 | -11.69 | -3.45 |
| Net Income to Common | -4.22 | -8.28 | -19.53 | -6.83 | -11.69 | -3.45 |
| Shares Outstanding (Basic) | 34 | 34 | 34 | 23 | 43 | 41 |
| Shares Outstanding (Diluted) | 34 | 34 | 34 | 23 | 43 | 41 |
| Shares Change (YoY) | 0.29% | 0.26% | 44.99% | -45.50% | 5.31% | - |
| EPS (Basic) | -0.12 | -0.24 | -0.57 | -0.29 | -0.27 | -0.08 |
| EPS (Diluted) | -0.12 | -0.24 | -0.57 | -0.29 | -0.27 | -0.08 |
| Free Cash Flow | -2.37 | -6.71 | -11.14 | -5.22 | -5.08 | -2.96 |
| Free Cash Flow Per Share | -0.07 | -0.20 | -0.33 | -0.22 | -0.12 | -0.07 |
| Gross Margin | 75.38% | 74.14% | 73.51% | 74.21% | 61.06% | 59.35% |
| Operating Margin | -6.44% | -15.88% | -48.67% | -41.22% | -152.67% | -1137.41% |
| Profit Margin | -7.45% | -16.45% | -54.81% | -31.26% | -272.36% | -1239.21% |
| Free Cash Flow Margin | -4.18% | -13.34% | -31.27% | -23.90% | -118.39% | -1063.67% |
| EBITDA | -2.65 | -7.13 | -16.77 | -8.87 | -6.52 | -3.15 |
| EBITDA Margin | -4.67% | -14.17% | -47.07% | -40.62% | -151.88% | - |
| D&A For EBITDA | 1 | 0.86 | 0.57 | 0.13 | 0.03 | 0.02 |
| EBIT | -3.65 | -7.99 | -17.34 | -9 | -6.55 | -3.16 |
| EBIT Margin | -6.44% | -15.88% | -48.67% | -41.22% | -152.67% | - |
| Advertising Expenses | - | 4.68 | 3.85 | 1.45 | 0.44 | 0.1 |
Source: S&P Capital IQ. Standard template. Financial Sources.